Paclitaxel is the first-line drug for breast cancer, and albumin paclitaxel for injection (Albumin Bound) is the first chemotherapeutic nano drug approved by Food and Drug Administration (FDA) and widely used in the clinical treatment of breast cancer (Weaver, 2014; Abu et al., 2019). Here, ALB is linked to breast carcinoma.